World Rural Health Conference
Home Print this page Email this page Small font size Default font size Increase font size
Users Online: 2528
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
Year : 2019  |  Volume : 8  |  Issue : 5  |  Page : 1653-1657

Comparing serum lead level in drug abuse pregnant women with non-addicted pregnant mothers referring to Shiraz university hospitals in 2017-2018

1 Department of Family Medicine and Pediatric Medicine, Neonatology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
2 Department of Family Medicine, Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran
3 Department of Family Medicine, Shiraz University of Medical Sciences, Shiraz, Iran

Correspondence Address:
Dr. Hourvash Haghighinejad
Department of Family Medicine, Shiraz University of Medical Sciences, Shiraz
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/jfmpc.jfmpc_36_19

Rights and Permissions

Introduction: In recent decades, there are multiple reports of lead poisoning in drug abusers in Iran and other Middle East countries. The lead in the mother's blood can cause many dangerous, harmful effects on the mother and the fetus. Therefore, in this study, we evaluated the blood lead level (BLL) in pregnant women who were an illegal drug user and compared it with pregnant women who did not use these agents. Method: A cross-sectional study was conducted among 60 pregnant women referred to Shiraz Hazrat Zinab and Hafez Hospitals. All pregnant women with a history of any drug abuse were sampled. Two pregnant women without any history of drug abuse were sampled for each pregnant mother with a history of drug abuse on the same day. To check BLL, 5 cc blood sample of all participants sent to a reference laboratory. BLLs have been assessed by atomic absorption spectrophotometry with GBC Avanta, and all reports were confirmed by a specific pathologist. The data were completed with maternal demographic information and infants' anthropometric indices. Data analysis was performed using SPSS software version 24, and the significance was 0.05. Results: There was a significant difference in BLL among pregnant women with and without drug abuse history (9.91 ± 26.2 and 2.95 ± 0.7, respectively) (P-value: 0.001). The prevalence of lead levels of more than 5 μg/dl in mothers with and without substance abuse was 20% and 7.5%, respectively. Anthropometric indices, Apgar score, and gestational age in the mothers with a history of drug abuse were significantly lower than the control group (a significant level less than 0.05). Conclusion: The level of lead in pregnant women taking illegal drugs is higher than that of the control group who do not have a history of illegal drug abuse. On the other hand, it is likely that increased serum levels of lead with fetal complications and maternal health threats childbirth and clinical outcomes during childbirth.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded64    
    Comments [Add]    

Recommend this journal